New drug targets Hard-to-Treat cancers with specific gene flaw
Disease control
Recruiting now
This study tests a new drug called PLX-61639 in adults with advanced solid tumors that have a specific genetic change (SMARCA4 mutation) and have stopped responding to standard treatments. The drug is taken daily by mouth and aims to shrink or control the cancer. The trial will e…
Phase: PHASE1 • Sponsor: Plexium, Inc. • Aim: Disease control
Last updated May 17, 2026 05:07 UTC